Health and Healthcare
5867 Articles
CV Therapeutics, Inc. (NASDAQ: CVTX) is seeing a surge in its shares this morning. It looks like CV is the…
Medidata Solutions, Inc. has filed with the SEC to come public via an initial public offering. The company has applied…
Thomas Alva Edison accumulated 1,093 US patents over his lifetime. Most R&D operations are not that efficient. Corporations hate research.…
Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over…
If we told you on Friday that a decent-sized medical merger was coming with a 100% premium, you probably wouldn’t…
La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been more than just a troubled biotech. It has even been considered an…
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is responding well in pre-market trading after the company signed an overseas commercialization agreement with…
Biogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies…
Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately. But shares have just now gotten back above the…
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…
Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week. Merck…
Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin…
So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock…
UnitedHealth Group Inc. (NYSE: UNH) has made some rather bold predictions for 2009. What is interesting here is that these…
Our top personal finance-related articles today. Your wallet will thank you later.